SPARC’s Q1 net loss widens to Rs 78.84 crore

Sun Pharma Advanced Research Company Ltd. | Business Support | Miscellaneous | BSE: 532872 | NSE: SPARC

07 Aug 2017 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for first quarter ended June 30, 2017.

The company has reported a net loss of Rs 78.84 crore for the quarter under review as against a net loss of Rs 36.14 crore for the same quarter in the previous year. However, total income of the company increased marginally by 0.49% at Rs 24.62 crore for Q1FY18 as compared Rs 24.50 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Peers

Company Name	CMP
Sagility	45.94
Prime Focus	352.35
Knowledge RealtyTrt.	113.71
Indegene	596.10
Syngene Internatl.	385.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.